Neuroone Medical Technologies (NMTC) EBITDA Margin (2010 - 2026)
Neuroone Medical Technologies (NMTC) posted EBITDA Margin of 128.74% for Q1 2026, down 118.12% on a QoQ basis from 59.02% in Q4 2025, and up 6455.0% year-over-year from 1.96% in Q1 2025.
Neuroone Medical Technologies (NMTC) EBITDA Margin (2010 - 2026) Analysis & Trends
Neuroone Medical Technologies' EBITDA Margin history runs 13 years deep, the most recent figure standing at 128.74% for Q1 2026.
- Quarterly EBITDA Margin rose 6455.0% year-over-year to 128.74% in Q1 2026, while the trailing twelve-month figure through Mar 2026 was 80.1% (up 3415.0% YoY) and the FY2025 annual result came in at 46.46%, up 29780.0% from the prior year.
- EBITDA Margin was 128.74% for Q1 2026 at Neuroone Medical Technologies, down from 59.02% in the prior quarter.
- Across five years, EBITDA Margin topped out at 52.26% in Q4 2024 and bottomed at 8616.29% in Q2 2022.
- A 5-year average of 1454.47% and a median of 346.8% in 2023 frame the typical range for EBITDA Margin.
- Annual changes were most pronounced in 2022 — EBITDA Margin tumbled 104696 bps — and 2023, when it soared 805902 bps.
- Neuroone Medical Technologies' EBITDA Margin stood at 1557.31% in 2022, then jumped by 78 bps to 346.8% in 2023, then surged by 115 bps to 52.26% in 2024, then slumped by 213 bps to 59.02% in 2025, then plunged by 118 bps to 128.74% in 2026.
- Business Quant data shows NMTC's EBITDA Margin at 128.74% in Q1 2026, 59.02% in Q4 2025, and 50.02% in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBITDA Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 201.40 Bn | 194.75 Bn | 6.27 Bn | 12.05% |
| 2 | Stryker | 122.29 Bn | 119.41 Bn | 3.81 Bn | 15.55% |
| 3 | Medtronic | 105.01 Bn | 96.40 Bn | 6.41 Bn | 19.10% |
| 4 | Boston Scientific | 64.81 Bn | 63.59 Bn | 3.61 Bn | 21.16% |
| 5 | Edwards Lifesciences | 55.28 Bn | 51.60 Bn | 1.29 Bn | 28.97% |
| 6 | Dexcom | 29.06 Bn | 27.94 Bn | 750.30 Mn | 21.42% |
| 7 | Koninklijke Philips | 29.02 Bn | 25.93 Bn | 2.07 Bn | 6.17% |
| 8 | GE HealthCare Technologies | 28.27 Bn | 26.20 Bn | 1.98 Bn | 10.04% |
| 9 | Smith & Nephew | 25.80 Bn | 25.22 Bn | - | - |
| 10 | Neuroone Medical Technologies | 7.99 Mn | 5.19 Mn | 990,264.00 | -128.74% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -128.74% |
| Dec 31, 2025 | -59.02% |
| Sep 30, 2025 | -50.02% |
| Jun 30, 2025 | -111.23% |
| Mar 31, 2025 | -193.29% |
| Dec 31, 2024 | 52.26% |
| Sep 30, 2024 | -1,034.48% |
| Jun 30, 2024 | -338.34% |
| Mar 31, 2024 | -209.55% |
| Dec 31, 2023 | -346.80% |
| Sep 30, 2023 | -426.64% |
| Jun 30, 2023 | -557.26% |
| Mar 31, 2023 | -749.91% |
| Dec 31, 2022 | -1,557.31% |
| Sep 30, 2022 | -2,035.52% |
| Jun 30, 2022 | -8,616.29% |
| Mar 31, 2022 | -8,363.79% |
| Dec 31, 2021 | -8,324.42% |
| Sep 30, 2021 | -5,470.30% |
| Jun 30, 2021 | -7,569.32% |